About Elixirgen Scientific, LLC
Elixirgen Scientific, launched in 2016, is a Baltimore-based biotechnology company focused on stem cell related technology. The company’s mission is to make stem cell innovation available to everyone. The industry’s top issue is the high cost and and inefficiencies in iterating research and development due to the long cell differentiation period from human pluripotent stem cells to specific human cells. The company is now providing reagents, kits, and services at an affordable price to help make research and other laboratory work more efficient.
Elixirgen Scientific, LLC is located in the Science + Technology Park at Johns Hopkins in Baltimore, an ideal research environment that allows Elixirgen Scientific’s scientists to conduct research at state-of-the-art facilities.
Chief Executive Officer – Bumpei Noda joined Elixirgen Scientific, LLC as a CEO. He has been responsible for business development, marketing, sales, and funding for further business growth and acceleration. Bumpei has worked for McKinsey and Company Inc., a global management consulting firm and ngmoco, LLC, a mobile application developer. He led strategy projects for pharmaceutical and chemical industry clients in the consulting firm and utilized such experience with strategic mindset for exponential growth on mobile business by managing global talents.
President – Akihiro Ko joined Elixirgen, LLC in 2015 and worked as Chief Operating Officer. Through his management efforts, he optimized the company’s business development and operations. With the establishment of Elixirgen Scientific, LLC, he assumed the position of President in August 2016. He has been responsible for business operations, marketing, and business development at Elixirgen Scientific. He earned a Bachelor of Science degree from University of Virginia, where he cultivated his interest in stem cell biology and epigenetics through his research involving bivalent domains in cancer stem cells.
Chief Scientific Advisor – Minoru S.H. Ko, M.D., Ph.D. is currently Professor and Chair at the Department of Systems Medicine, Keio University School of Medicine. He also worked as Senior Investigator (tenured) and Section Chief for nearly 15 years at the National Institute on Aging, a division of the National Institutes of Health. He has published more than 150 peer-reviewed scientific articles and more than 20 other articles and book chapters, including a “Stem Cell Biology” chapter of Harrison’s Principles of Internal Medicine (17th, 18th, 19th editions). He brings more than 30 years of experience in stem cell biology, genetics, molecular and cell biology, and systems biology.